Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial
Titel:
Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial
Auteur:
Smilowitz, Nathaniel R. Hade, Erinn M. Kornblith, Lucy Z. Castellucci, Lana A. Cushman, Mary Farkouh, Michael Gong, Michelle N. Heath, Anna Hunt, Beverly J. Kim, Keri S. Kindzelski, Andrei Lawler, Patrick Leaf, David E. Goligher, Ewan Leifer, Eric S. McVerry, Bryan J. Reynolds, Harmony R. Zarychanski, Ryan Hochman, Judith S. Neal, Matthew D. Berger, Jeffrey S.
Verschenen in:
Research and practice in thrombosis and haemostasis